AI Summary
Thinking
Thinking
We reviewed 3 live results for trade reporting and narrowed them down to the 3 options that look most worth comparing first.
The options are Derivative Trade Reporting, Amelieff Omics Reporting Package and EMIR REFIT Trade Reporting.
Source: Kooltra
Description
Kooltra Derivative Trade Reporting is a compliance automation platform built on Salesforce designed to streamline foreign exchange derivative reporting workflows. Integrated with KOR Financial and DTCC trade repositories, it supports reporting obligations across jurisdictions including Canada (CSA), the United States (CFTC), Australia (ASIC), and Singapore (MAS). The platform handles trade ingestion via REST API, bulk upload, or manual entry, alongside UTI enrichment, lifecycle event tracking, exception remediation, and audit logging for products such as forwards, NDFs, swaps, and options.
Best for
money service businesses, fintechs, foreign exchange derivative trade reporting and regulatory compliance automation for CSA, CFTC, ASIC, and MAS
Rate this product
Source: アメリエフ株式会社
Description
「Amelieff Omics Reporting Package」は、オミクスデータを扱う研究機関や企業向けのデータ解析基盤システムです。RNAseqやWES遺伝性変異解析などの解析を簡便な操作で実行し、多検体データや臨床情報等のメタデータを管理するインハウスデータベース構築やメタアナリシスなどの高度な解析に対応します。
Best for
研究機関, 製品開発企業, オミクスデータ解析 and インハウスデータベースの構築・管理
Rate this product
Source: Reg-X Innovations
Description
EMIR REFIT Trade Reporting by Reg-X is a regulatory compliance platform and solution designed to assist entities with mandatory derivative transaction reporting under EMIR regulations. The platform provides automated data collection and submission to authorized trade repositories, alongside data validation tools to ensure accurate and timely reporting. In addition, Reg-X offers real-time regulatory compliance alerts, analytics, insights, and consulting services tailored to help clients navigate cross-border reporting complexities and meet regulatory deadlines.
Best for
financial entities, derivatives market participants, EMIR Refit compliance and trade repository reporting
Rate this product
| Compare | #1Derivative Trade Reporting | #2Amelieff Omics Reporting Package | #3EMIR REFIT Trade Reporting |
|---|---|---|---|
| Source | Kooltra | アメリエフ株式会社 | Reg-X Innovations |
| Description | Kooltra Derivative Trade Reporting is a compliance automation platform built on Salesforce designed to streamline foreign exchange derivative reporting workflows. Integrated with KOR Financial and DTCC trade repositories, it supports reporting obligations across jurisdictions including Canada (CSA), the United States (CFTC), Australia (ASIC), and Singapore (MAS). The platform handles trade ingestion via REST API, bulk upload, or manual entry, alongside UTI enrichment, lifecycle event tracking, exception remediation, and audit logging for products such as forwards, NDFs, swaps, and options. | 「Amelieff Omics Reporting Package」は、オミクスデータを扱う研究機関や企業向けのデータ解析基盤システムです。RNAseqやWES遺伝性変異解析などの解析を簡便な操作で実行し、多検体データや臨床情報等のメタデータを管理するインハウスデータベース構築やメタアナリシスなどの高度な解析に対応します。 | EMIR REFIT Trade Reporting by Reg-X is a regulatory compliance platform and solution designed to assist entities with mandatory derivative transaction reporting under EMIR regulations. The platform provides automated data collection and submission to authorized trade repositories, alongside data validation tools to ensure accurate and timely reporting. In addition, Reg-X offers real-time regulatory compliance alerts, analytics, insights, and consulting services tailored to help clients navigate cross-border reporting complexities and meet regulatory deadlines. |
| Best for | money service businesses, fintechs, foreign exchange derivative trade reporting and regulatory compliance automation for CSA, CFTC, ASIC, and MAS | 研究機関, 製品開発企業, オミクスデータ解析 and インハウスデータベースの構築・管理 | financial entities, derivatives market participants, EMIR Refit compliance and trade repository reporting |
| Action | Kooltra | アメリエフ株式会社 | Reg-X Innovations |
| Rate this product |
"Derivative Trade Reporting from Kooltra."
Note: TopFind AI compiles financial product information for general comparison purposes only. It does not constitute financial advice.